Literature DB >> 12218076

Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice.

Pierre François Piguet1, Chen Da Kan, Christian Vesin.   

Abstract

Infection of susceptible mice with Plasmodium berghei Anka leads to a syndrome of severe or cerebral malaria. Tumor necrosis factor (TNF) contributes to this syndrome, apparently by acting on its receptor 2 (TNFR2) because TNFR1-/- are susceptible, whereas TNFR2-/- mice are resistant. In this work, we confirmed the essential role of the TNFR2 in cerebral malaria because 6 to 8 days after Plasmodium berghei Anka infection, hypothermia, coma, and death were observed in +/+ or TNFR1-/-, but never in TNFR2-/-, mice. TNF production, evaluated by the serum levels or the mRNA levels in the brain, spleen or lung, was similar in +/+, TNFR1-/-, or TNFR2-/- mice. Macrophage or parasitized red blood cell sequestration in brain or lung was similar in TNFR1-/- and TNFR2-/- mice. Accordingly, up-regulation of CD54 or CD40 in brain or lung was also similar in TNFR1-/- or TNFR2-/- mice. Platelet loss, manifested by thrombocytopenia and the presence of microparticles in plasma, was similar in TNFR1-/- or TNFR2-/- mice. Breakdown of the blood-brain barrier, detected by the diffusion of tracers, was attenuated in both TNFR1-/- and TNFR2-/-, compared with +/+, mice. Endothelial cells from brain capillaries, examined by transmission electron microscopy, were similar in infected TNFR1-/- or TNFR2-/- mice, whereas the basement membrane was enlarged in TNFR1-/- mice. Hypothermic mice were also hyperglycemic, and this was evident in +/+ and TNFR1-/-, but not in TNFR2-/-, mice. In addition, infected +/+ and TNFR1-/- mice became insulin resistant, while in contrast TNFR2-/- became extremely insulin sensitive. This study supports the possibility that coma and death are mediated not by cell sequestration or breakdown of vascular permeability, similar in TNFR1-/- or TNFR2-/- mice, but by metabolic disturbances selectively mediated by the TNFR2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218076     DOI: 10.1097/01.lab.0000028822.94883.8a

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections.

Authors:  M F Fontana; A Baccarella; D Kellar; T K Oniskey; P Terinate; S D Rosenberg; E J Huang; D R Herbert; C C Kim
Journal:  Parasite Immunol       Date:  2015-09       Impact factor: 2.280

2.  Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus.

Authors:  Lucy A Perrone; Kristy J Szretter; Jacqueline M Katz; Joseph P Mizgerd; Terrence M Tumpey
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

Review 3.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

4.  Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice.

Authors:  Tamio Ohno; Fumie Kobayashi; Masahiko Nishimura
Journal:  Immunogenetics       Date:  2005-04-02       Impact factor: 2.846

Review 5.  Host resistance to malaria: using mouse models to explore the host response.

Authors:  Rhea Longley; Clare Smith; Anny Fortin; Joanne Berghout; Brendan McMorran; Gaétan Burgio; Simon Foote; Philippe Gros
Journal:  Mamm Genome       Date:  2010-11-30       Impact factor: 2.957

Review 6.  Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.

Authors:  S Balachandar; A Katyal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-09       Impact factor: 3.267

Review 7.  Microbial induction of vascular pathology in the CNS.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-18       Impact factor: 4.147

Review 8.  The role of platelets in the pathogenesis of cerebral malaria.

Authors:  Dermot Cox; Sam McConkey
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

9.  Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.

Authors:  Pamela Orjuela-Sánchez; Peng Kai Ong; Graziela M Zanini; Benoît Melchior; Yuri C Martins; Diana Meays; John A Frangos; Leonardo J M Carvalho
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

10.  Linkage and association analysis of candidate genes for TB and TNFalpha cytokine expression: evidence for association with IFNGR1, IL-10, and TNF receptor 1 genes.

Authors:  Catherine M Stein; Sarah Zalwango; Allan B Chiunda; Christopher Millard; Dmitry V Leontiev; Amanda L Horvath; Kevin C Cartier; Keith Chervenak; W Henry Boom; Robert C Elston; Roy D Mugerwa; Christopher C Whalen; Sudha K Iyengar
Journal:  Hum Genet       Date:  2007-04-13       Impact factor: 5.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.